{"id":181379,"name":"(\"BIO\") BIOTECHNOLOGY INDUSTRY ORGANIZATION","slug":"bio-biotechnology-industry-organization","state":"DC","country":"United States of America","description":"","totalSpending":960000,"filings":32,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":120000},{"year":2025,"income":120000}],"issues":["FIN"],"firms":["PORTERFIELD, FETTIG & SEARS, LLC"],"lobbyists":["LENDELL PORTERFIELD","DWIGHT FETTIG","DAWN SEARS","JEREMY RABINOVITZ","BRYAN BLOM","BENJAMIN TURNER","KELLY MCGRATH","JENNIFER READ","STEPHEN NEWTON","ABIGAIL TRUHART","CHRIS MANEVAL"],"govEntities":["HOUSE OF REPRESENTATIVES","Securities & Exchange Commission (SEC)","SENATE"],"sampleDescriptions":["Issues related to capital formation and capital markets; implementation of the JOBS Act; market structure; HR.1645, Fostering Innovation Act; S.2155, Economic Growth, Regulatory Relief, and Consumer P","Issues related to capital formation and capital markets; implementation of the JOBS Act; market structure; HR.1645, Fostering Innovation Act; S.2155, Economic Growth, Regulatory Relief, and Consumer P","Issues related to capital formation and capital markets; implementation of the JOBS Act; market structure; HR.1645, Fostering Innovation Act; HR. 4015, Corporate Governance Reform and Transparency Act","Issues related to capital formation and capital markets; implementation of the JOBS Act; market structure; HR. 1645, Fostering Innovation Act; HR. 4015, Corporate Governance Reform and Transparency Ac","Issues related to capital formation and capital markets; implementation of the JOBS Act; market structure; Fostering Innovation Act; issues related to smaller reporting companies; short selling transp"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}